CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
PERSONAL INFORMATION
DATE OF BIRTH
December 29, 1961
PLACE OF BIRTH
Buffalo, NY.
OFFICE ADDRESS
1537 State St.
Sarasota, FL. 34236
(941) 330-1696
E-MAIL
Dr.Voelker@comcast.net
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
ACADEMIC RECORD
UNDERGRADUATE
University of FL.
Gainesville, FL.
August, 1980-May, 1985
Degree-Bachelor of Science, Engineering
Biomedical Engineering)
MEDICAL SCHOOL
University of FL.
Gainesville, FL.
August, 1985-May, 1989
Degree-Doctor of Medicine
INTERNSHIP
Orlando Regional Medical Center
1414 S. Kuhl Ave.
Orlando, FL.
July, 1989-June, 1990
RESIDENCY
Orlando Regional Medical Center
1414 S. Kuhl Ave.
Orlando, FL.
July, 1990-June, 1992
CHIEF RESIDENT
Orlando Regional Medical Center
1414 S. Kuhl Ave.
Orlando, FL.
July, 1991-June, 1992
FELLOWSHIP
Pulmonary & Critical Care Medicine
University of CA. at Irvine
Long Beach, VA.
July, 1992-June, 1995
Suncoast Lung Ctr.
November, 1995-July, 1997
Sarasota, FL.
Solo Practice
July, 1997-August, 1997
Sarasota, FL.
Lung Associates
of Sarasota
Partner- August, 1997- June 2005
Sarasota, FL.
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
Solo Practice
June 2005- Present
AMI Stop Smoking
Clinics
Founder - January 2004- Present
Quit Doc Smoking
Treatment Network
Co-Founder June 2006- Present
HOSPITAL AFFILIATIONS
Sarasota Memorial Hospital
Sarasota, FL.
12/95-Present
Doctors Hospital of Sarasota
Sarasota, FL.
11/95-2006
HEALTHSOUTH Rehabilitation Hospital
Sarasota, FL.
05/97-Present
LICENSURE
FL
CA
ME58833
GO73832
BOARD CERTIFICATION
American Board of Internal Medicine
Internal Medicine
1992
Pulmonary Medicine
11/94
Critical Care Medicine
11/95
MEMBERSHIP
American College of Chest Physicians
American College of Physicians
American Medical Association
American Thoracic Society
(UCI Fellowship Representative `92-`94)
Florida Medical Association
(Regional Representative `90-`92)
Orange County Medical Society
(Resident Representative `90-`92)
Society of Critical Care Medicine
Sarasota County Medical Society
PUBLICATIONS
Co-Author
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
Current Clinical Strategies in Critical
Care Medicine (second ed.)
1993: Clinical Strategies Publishing:
Fountain Valley, CA.
Co-Author
Current Clinical Strategies in Critical
Care Medicine (third ed.) 1995:
PUBLICATIONS(Cont)
Pulm. Vascular and Thromboembolic Dis.
Chapter in: Handbook of Pulmonary and
Critical Care Medicine
Brenner M, Williams J.
Diagnostic and Treatment Strategies in
Massive Hemoptysis
Chapter in: Handbook of Pulmonary and
Critical Care Medicine
Brenner M, Williams J.
Sasse S, Voelker K, Mahutte CK
Arterial Oxygenation Time after an
Increase in the Concentration of
Inspired Oxygen in Mechanically
Ventilated Medical ICU Pts.
American Journal of Respiratory and
Critical Care
Voelker K, Chetty C, Sasse S,Mahutte CK
Tracheomalacia Presenting as COPD.
CHEST
Voelker K, Chetty C, Mahutte CK
RhDNAse in the Treatment of Atelectasis
in Spinal Cord Patients
Critical Care Medicine
Improved Diagnostic Sensitivity for
Lung Cancer Using an Automated
Quantitative Cytology System and
Uridine 5'-Triphosphate-Induced Sputum
Specimens. Chest, May 2004; 125: 157S
- 158S
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
Efficacy Of A County Government
Employee Benefits Smoking Cessation
Program Utilizing An Anticholinergic
Intramuscular Injection Combined With
Counseling
Chest Meeting Abstracts, Oct 2005; 128:
387s.
PUBLICATIONS(Cont)
Safety And Efficacy Of An
Anticholinergic Injection Used In A
Community Smoking Cessation Clinic
Chest Meeting Abstracts, Oct 2004; 126:
713s.
PROCEDURES
All aspects of pulmonary and critical
care medicine, including training in:
-Hyperbaric Oxygen Therapy
-Rigid Bronchoscopy
-Laser Bronchoscopy
-Percutaneous Tracheostomy
-Stent Placement
-Thoracoscopy
-Ultrasonic Bronchoscopy
-Argon Plasma Coagulation Bronchoscopy
-Photodynamic Therapy Bronchoscopy
-Endobronchial Volume Reduction Surgery
RESEARCH
Clinical Research Center
1425 S. Osprey Ave., Suite 7
Sarasota, FL. 34239
CLINICAL TRIALS CONDUCTED IN CONJUNCTION WITH CLINICAL RESEARCH
CENTER OF SARASOTA MEMORIAL HOSPITAL:
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). Bayer Drug Study #98-PULM-45. Prospective,
randomized, double-blind, multicenter comparison of the safety
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
and efficacy of Moxifloxacin 400 mg QD for five days versus
Azithromycin 250 mg QD (500 mg QD on the first day) for five
days in the treatment of acute exacerbation of chronic
bronchitis. Protocol #100160. (December, 1997-February, 1999)
Sub-Investigator Clinical Research Center of Sarasota Memorial
Hospital). Bayer Drug Study #99-PULM-55. Prospective,
randomized, double-blind, multicenter comparison of the safety
and efficacy of Moxifloxacin 400 mg QD for five days versus
Levofloxacin 500 mg QD for seven days in the treatment of acute
exacerbation of chronic bronchitis. Protocol #100243 (October,
1999-May, 2000)
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). Bayer #00-PULM-39. Prospective, randomized, doubleblind study comparing Faropenem Daloxate 300 mg PO BID for 5
days with Azithromycin for 5 days (500 mg PO day 1, then 250 mg
PO OD days 2-5) in the treatment of patients with acute
exacerbation of chronic bronchitis. Protocol #100291 (December,
2000-2001)
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). #99-PULM-47. A Phase II, multicenter, randomized,
double-blind, placebo-controlled, parallel group, dose-ranging
evaluation of the safety and efficacy of a-hANP infusion
(Carperitide for injection: SUN 4936) in patients with acute
respiratory distress syndrome (ARDS). Protocol #SPI-001 (July,
2000-2002)
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). A one-year randomized, double-blind, placebo and
active-controlled parallel design safety and efficacy comparison
of COMBIVENT HFA Inhalation Aerosol to COMBIVENT CFC Inhalation
Aerosol in patients with COPD. (November, 2000-2002)
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). #00-MEDI-21. A randomized, open-label, pilot
assessment of the effect of Protonix Iv for injection
(Pantoprazole Sodium) on gastric Ph in ICU patients. (August,
2000-2002)
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). A randomized, multicenter, open-label trial
comparing intravenous Zithromax (Azithromycin) plus intravenous
Rocephin (Ceftriaxone) followed by oral Zithromax (Azithromycin)
with intravenous Levaquin (Levofloxacin) followed by oral
Levaquin (Levofloxacin) for the treatment of moderate to
severely ill subjects with community-acquired pneumonia.
Protocol #A0661035 (December, 2000-2002)
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital). A randomized, double-blind, multicenter study to
evaluate the effect of adding either Montelukast Sodium or
Salmeterol Xinafoate to inhaled Fluticasone in adult asthmatics.
(February, 2000-December, 2000)
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A one-year randomized, double-blind, placebo and
active controlled parallel design safety and efficacy comparison
of COMBIVENT HFA Inhalation Aerosol to COMBIVENT® (CFC)
Inhalation Aerosol in patients with COPD
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A Prospective, randomized, double-blind, multicenter
outpatient trial comparing the safety and efficacy of
moxifloxacin 400 mg PO QD for 5 days vs. azithromycin 500 mg PO
loading dose on day 1, then 250 mg PO QD for 4 days for the
treatment of Acute Exacerbations of Chronic Bronchitis ( The
QUICK Study)
STUDY NUMBER: 100314
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A Randomized, 24-week, Double-blind, Placebocontrolled, Parallel-group Study to Evaluate the Efficacy,
Safety and Tolerability of Ariflo (15 mg BID) in Patients with
Chronic Obstructive Pulmonary Disease (COPD) 00-PULM-51
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) Prospective, randomized, double-blind study comparing
Faropenem Daloxate 300mg PO BID for 5 days with Azithromycin for
5 days (500mg PO day 1, then 250 mg PO OD days 2-5) in the
treatment of patients with acute exacerbation of chronic
bronchitis. Bayer Protocol 100291 #00-PULM-39.
CURRICULUM VITAE
KIRK GEORGE VOELKER, M.D.
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A Randomized, Open-Label, Pilot Assessment Of The
Effect Of Protonixa Iv For Injection (Pantoprazole Sodium) On
Gastric Ph In ICU patients.
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A Multicenter, Randomized, Open-Label Study Comparing
The Efficacy And Safety Of Once Daily (O.D.) Org 31540/Sr90107a
Versus Adjusted-Dose Intravenous (Iv) Unfractionated Heparin
(Ufh) In The Initial Treatment Of Acute Symptomatic Pulmonary
Embolism (PE) 01-PULM-03
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A Double-Blinded, Placebo-Controlled, Parallel Group
Study of Uridine 5-Triphosphate (UTP) Solution for Inhalation as
an Adjunct in the Diagnosis of Lung Cancer by Sputum Cytology
(Inspire Lung CA) 01-PULM-12
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) Title: A randomized, double-blind, placebocontrolled, parallel group trial assessing the rate of decline
of lung function with tiotropium 18 mcg inhalation capsule once
daily in patients with chronic obstructive pulmonary disease
(COPD). SPONSOR: Boehringer Ingelheim Pharmaceuticals, Inc.
02-PULM-21
Sub-Investigator (Clinical Research Center of Sarasota Memorial
Hospital) A multicentre, randomized, double-blind, parallel
group, placebo-controlled study to investigate the long-term
effects of salmeterol/fluticasone propionate
(Seretide™/Viani™/Advair™) 50/500mg bd, salmeterol 50mg bd and
fluticasone propionate 500mg bd, all delivered via the
Diskus/™Accuhaler™ inhaler, on the survival of subjects with
chronic obstructive pulmonarydisease (COPD) over 3 years of
treatment. 02-PULM-20
Principle-Investigator (Clinical Research Center of Sarasota
Memorial Hospital). Endobronchial Valve for Emphysema Palliation
Trial (VENT) (February 2004- Present